| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2083 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1500 | 2018 |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ... The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017 | 309 | 2017 |
| HIV testing history and access to treatment among migrants living with HIV in Europe I Fakoya, D Álvarez‐Del Arco, S Monge, AJ Copas, AF Gennotte, ... Journal of the International AIDS Society 21, e25123, 2018 | 54 | 2018 |
| Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high‐prevalence setting? I Gountas, V Sypsa, O Anagnostou, N Martin, P Vickerman, ... Addiction 112 (7), 1290-1299, 2017 | 49 | 2017 |
| HCV elimination among people who inject drugs. Modelling pre-and post–WHO elimination era I Gountas, V Sypsa, S Blach, H Razavi, A Hatzakis PloS one 13 (8), e0202109, 2018 | 38 | 2018 |
| Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals I Gountas, V Sypsa, G Papatheodoridis, K Souliotis, K Athanasakis, ... World Journal of Gastroenterology 25 (11), 1327, 2019 | 23 | 2019 |
| Act early, save lives: managing COVID-19 in Greece I Gountas, G Hillas, K Souliotis Public health 187, 136-139, 2020 | 15 | 2020 |
| Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece I Gountas, V Sypsa, G Papatheodoridis, G Souliotis, H Razavi, A Hatzakis Journal of Gastroenterology and Hepatology 32 (2), 466-472, 2017 | 12 | 2017 |
| High-risk behaviors and their association with awareness of HIV status among participants of a large-scale prevention intervention in Athens, Greece ID Pavlopoulou, SK Dikalioti, I Gountas, V Sypsa, M Malliori, K Pantavou, ... BMC Public Health 20, 1-14, 2020 | 11 | 2020 |
| A hepatitis C outbreak preceded the HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study I Gountas, V Sypsa, G Papatheodoridis, D Paraskevis, G Kalamitsis, ... Journal of viral hepatitis 26 (11), 1311-1317, 2019 | 8 | 2019 |
| Impact of the COVID-19 pandemic on HPV vaccinations in Switzerland and Greece: road to recovery I Gountas, A Favre-Bulle, K Saxena, J Wilcock, H Collings, ... Vaccines 11 (2), 258, 2023 | 7 | 2023 |
| Are ALOX5AP gene SNPs a risk or protective factor for stroke? A Papapostolou, K Spengos, I Fylaktou, M Poulou, I Gountas, ... Gene 548 (1), 56-60, 2014 | 5 | 2014 |
| Effect of public health interventions during the first epidemic wave of COVID-19 in Cyprus: a modelling study I Gountas, A Quattrocchi, I Mamais, C Tsioutis, E Christaki, K Fokianos, ... BMC Public Health 21, 1-8, 2021 | 4 | 2021 |
| Could the 2010 HIV outbreak in Athens, Greece have been prevented? A mathematical modeling study I Gountas, G Nikolopoulos, G Touloumi, A Fotiou, K Souliotis Plos one 16 (10), e0258267, 2021 | 4 | 2021 |
| The cost of a late-detected outbreak among people who inject drugs. a modeling study I Gountas, A Hatzakis, G Nikolopoulos, G Touloumi, K Souliotis International Journal of Drug Policy 88, 103032, 2021 | 3 | 2021 |
| Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis C Thomadakis, I Gountas, E Duffell, K Gountas, B Bluemel, T Seyler, ... The Lancet Regional Health–Europe 36, 2024 | 1 | 2024 |
| Estimation of prevalence of chronic HCV infection in EU/EEA countries using multiparameter evidence synthesis I Gountas, C Thomadakis, E Duffell, K Gountas, B Bluemel, T Seyler, ... International Liver Congress 78 (1), S1-S1314-S1-S1314, 2023 | 1 | 2023 |
| Health-economic evaluation of fast-track hepatitis C micro-elimination program among people who inject drugs receiving oral substitution therapy in the hellenic organization … I Gountas, O Anagnostou, E Petroulaki, K Kokkolis, A Dimitriadis, ... Hepatology 74, 591A-592A, 2021 | 1 | 2021 |
| Planning the hepatitis C virus elimination in Cyprus: A modeling study I Gountas, I Yiasemi, E Kyprianou, C Mina, C Georgiou, P Katsioloudes, ... World Journal of Gastroenterology 27 (31), 5219, 2021 | 1 | 2021 |
